Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113861086A details a novel Pd-catalyzed route for sulfur-containing diarylamine butyramides, offering mild conditions and simplified purification for pharmaceutical supply chains.
Patent CN114411180B reveals a green electrochemical method for constructing thio(seleno)phosphoric acid esters, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
This patent details asymmetric hydrogenation for hydantoin derivatives offering high selectivity and atom economy for scalable pharmaceutical intermediate manufacturing supply chains.
Discover a novel one-pot palladium-catalyzed method for synthesizing indole sulfoxides from patent CN115181051A. Efficient route for pharmaceutical intermediates with mild conditions.
Patent CN107759458B details a metal-free synthesis of alpha-unsaturated ketones using DMSO. This method offers high yields, reduced costs, and eliminates heavy metal catalysts for reliable pharmaceutical intermediate supply.
Patent CN110407830A reveals air-oxidized Cu-catalyzed route for N-aryl phenothiazine. Offers green manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN112028955B details a novel 1,3-dipolar cycloaddition route for potent antitumor spiroisoxazole-pyrrolizine derivatives, offering scalable manufacturing and cost-effective supply chain solutions.
Patent CN102984945B details a high-yield asymmetric hydrogenation process for Ramipril and Perindopril intermediates, offering significant cost and purity advantages for pharmaceutical supply chains.
Patent CN110183467B details a novel 1,3-dipolar cycloaddition route for spiro-indazole derivatives, offering cost-effective manufacturing and high purity for antitumor applications.
Patent CN101302195B reveals a solid-acid catalyzed synthesis for 7-Hydroxy-3,4-dihydroquinolone, offering high purity and reduced environmental impact for Aripiprazole manufacturing.
Patent CN110294689B details a green ruthenium-catalyzed method for converting primary amines to nitriles with high yield and hydrogen byproduct.
Patent CN115448926A details a scalable method for indolinobenzodiazepine derivatives using iron reduction and palladium catalysis, offering significant cost reduction in API manufacturing.
Patent CN104650025A details a transition-metal-free method for benzoxepin synthesis, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
This novel ruthenium catalyst method ensures high dr value and cost reduction in pharmaceutical intermediates manufacturing for reliable supply chain partners globally.
Novel PPh3-mediated one-pot synthesis of indol-3-one intermediates offers cost-effective, scalable routes for pharmaceutical manufacturing supply chains.
Patent CN115368258B reveals efficient Beckmann rearrangement. Cost reduction in pharmaceutical intermediates manufacturing. High purity and scalability for global supply chains and partners.
Novel 3,4-diaminopyridine catalyst enables high-yield asymmetric synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes globally.
Patent CN111018734B reveals a cost-effective route for cinacalcet intermediates using Meldrum's acid, offering reliable supply chain solutions and reduced manufacturing costs for global pharma.
Patent CN118771989A reveals a novel manganese catalyst for amide reduction. This technology offers cost-effective, scalable solutions for high-purity pharmaceutical intermediate manufacturing.
Advanced synthesis of 2-methoxy-4-methylbenzylamine via safe reductive amination. Offers significant cost reduction in fine chemical manufacturing and high purity.